Table 1

Description of melanoma patients

Melanoma patient no.SexAgeStage of diseaseaClinical evidences of diseaseL-Ferritin (μg/L)bH-Ferritin (μg/L)bRatio H-Ferritin: L-Ferritin% of CD4+CD25+CD69 regulatory T cells
1M20IIINo96.5197.62.0n.a.c
2M23IVYes80.4103.01.314.9%
3F30IVYes33.6121.23.6n.a.
4F30IINo3.012.74.2n.a.
5M40IVYes131.5272.12.18.9%
6F40IIINo73.9170.12.317.3%
7M45IIINo86.3245.32.8n.a.
8M47IIINo101.3221.02.213.8%
9M48IINo162.2381.22.415.9%
10M53IVYes135.9238.61.8n.a.
11M53IINo149.7413.52.811.4%
12F54IINo87.6166.51.94.4%
13M56IINo117.1393.33.4n.a.
14F59IVYes171.2368.42.26.1%
15F60IVYes116.6203.51.77.5%
16M60IIINo122.3209.11.719.1%
17F62IIIYes29.854.51.813.7%
18M63IVNo30.757.01.918.3%
19M64IINo160.1339.52.1n.a.
20M66IVNo121.3283.12.314.9%
21M67IVNo102.2170.01.7n.a.
22F68IIINo73.8173.62.4n.a.
23M68IIINo165.4365.72.215.7%
24M69IVNo133.0443.13.312.9%
25F71IVNo42.765.21.526.6%
26M76IINo53.2132.32.520.6%
27M77IVYes32.257.21.828.9%
28M77IIINo105.4346.63.314.6%
29M78IIYes146.8285.81.9n.a.c
30M82IVNo120.0284.72.414.2%
  • a Using the AJCC and the International Union against Cancer Classification.

  • b Detection using ferritin ELISA.

  • c Not available.